Myelolipoma is a benign neoplasm, most commonly involving the adrenal gland, composed of mature adipose tissue and hematopoietic elements.
This tumor in most instances occurs in the adrenal cortex, although extra-adrenal sites, such as presacral region, retroperitoneum, and mediastinum have been reported (Abecassis et al. 1985; Decmann et al. 2018; Dann et al. 2008; Minamiya et al. 1997). It occurs over a wide age range, with 51 years as the average age of onset, including female predilection (Decmann et al. 2018; Wagnerová et al. 2004). Average tumor size is 10.2 cm. Nearly 10% cases are associated with adrenal hyperplasia (Abecassis et al. 1985). Other adrenal hypersecretory disorders have been reported in nearly 8% cases (Abecassis et al. 1985; Decmann et al. 2018).
Most patients harboring these tumors are asymptomatic and usually a myelolipoma is incidentally identified during autopsies (incidentaloma), in about 0.2% cases (Abecassis et al. 1985)....
- Bishop, E., Eble, J. N., Cheng, L., Wang, M., Chase, D. R., Orazi, A., & O'Malley, D. P. (2006). Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: Support for a clonal origin of myelolipomas. The American Journal of Surgical Pathology, 30, 838–843.CrossRefGoogle Scholar
- Pilotti, S., Della Torre, G., Lavarino, C., Di Palma, S., Sozzi, G., Minoletti, F., Rao, S., Pasquini, G., Azzarelli, A., Rilke, F., & Pierotti, M. A. (1997). Distinct mdm2/p53 expression patterns in liposarcoma subgroups: Implications for different pathogenetic mechanisms. The Journal of Pathology, 181, 14–24.CrossRefGoogle Scholar